Company will commit $10 million over 10 years.

Abraxis BioScience and the California NanoSystems Institute (CNSI) at UCLA are partnering to advance research in nanobiotechnology.

Abraxis will contribute $10 million over 10 years for projects in the new CNSI building at UCLA, or the Abraxis/CNSI Research Collaboration Lab space.

Abraxis also became CNSI’s first partner in the area of pharmaceuticals and biotechnology through the institute’s Partners Program. The collaboration provides CNSI and Abraxis researchers the opportunity to jointly pursue innovative approaches to the diagnosis and treatment of life-threatening diseases.

Previous articleGSK Relinquishes Right to Exelixis’ NSCLC Drug
Next articleOsiris and Genzyme to Develop Countermeasures for Nuclear and Radiological Threats